Hello Avatar! Welcome to another week of biotech analysis. As always on Thursday todays commentary is focused on general market updates. Recently things seem directionally correct for the sector as a whole. The summer relief rally continues on, propelled forward by high impact news flow. The public markets continue their recovery with secondary finan…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.